Solvent-screening and co-crystal screening for drug development with COSMO-RS by Klamt, A
ORAL PRESENTATION Open Access
Solvent-screening and co-crystal screening for
drug development with COSMO-RS
A Klamt
From 7th German Conference on Chemoinformatics: 25 CIC-Workshop
Goslar, Germany. 6-8 November 2011
Bringing active pharmaceutical or agrochemical ingredi-
ents (APIs) in solution often is the most demanding
step in pharmaceutical and agrochemical development.
The COSMO-RS method, which has been originally
developed by the author during his 12 years at Bayer, is
a unique combination of quantum chemical information
and liquid phase thermodynamics and currently is pro-
ven to be the most accurate method for predicting the
free energy of molecules in solution. Based on COSMO-
RS theory the COSMOtherm suite of software tools is
able to address a broad range of important aspects of
solubilization and thus is an ideally suited toolset for
rational solubilization development:
- Solvent screening, including mixtures and variable
temperatures
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distribution
- conformational preference and tautomer trends in
solution
- Co-crystal screening based on mixing enthalpy
- solubility in micellar systems
- solvent-dependent free energy of crystal faces
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